UNSPSC 85621601: Revision of infusion device in endocrine gland, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in endocrine gland, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0GWS33Z

UNSPSC 85621601 Revision of infusion device in endocrine gland, percutaneous approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code's nominal scope—a specific surgical procedure for modifying endocrine infusion devices—does not match the medical and administrative services actually being solicited by state and local bodies under this classification. Recent opportunities tagged to this code span independent medical evaluations for disability benefit determinations, surgical benefit carve-outs for municipal employee health plans, occupational medical surveillance, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary clinical staffing placement. None of these services involve endocrine infusion device revision or percutaneous surgical intervention. The issuing bodies include city retirement offices (Phoenix), municipal health plan administrators (Long Beach), state transportation departments (Washington), county juvenile justice systems (Harris County, Texas), county commissioners (Collier County, Florida), and county health systems (Santa Clara County, California)—a geographically dispersed mix spanning Arizona, California, Florida, Texas, and Washington with no pattern of repeat buyers under this code.

The persistent mismatch between the code's procedural scope and the administrative, staffing, and benefit-management services appearing in recent solicitations indicates either systemic miscoding of opportunities or fundamental divergence between the code's intended use and state and local procurement practice. No state or local entity has posted a solicitation for endocrine infusion device revision services under this code in the recent-opportunities window. Bid professionals evaluating this code should verify opportunity tagging with source procurement offices before investing pursuit resources, as the code does not currently reflect a coherent buying category within state and local markets.